Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib. - Zhu Z; Turner NC; Loi S; André F; Martin M; Diéras V; Gelmon KA; Harbeck N; Zhang C; Cao JQ; Yan Z; Lu DR; et al. (NPJ precision oncology, 2022)